Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Clinical trial NCT03526549 · COMPLETED
Trial details
- NCT number
- NCT03526549
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2021-10-08
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.